Pharmacogenomics-Supported Psychotropic Prescribing Trial

Recruiting now · Not applicable

Conditions studied: Mental Disorder, Pharmacogenetics, Adverse Drug Reaction (ADR), Effectiveness

In brief

Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.

Key facts

Study ID

NCT06929533

Run by

University of Manitoba

People needed

200

Starts

2025-07-01

Expected to finish

2030-12-31

Last updated by the study team

2025-09-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18 years or older
• The initiation, change, dose adjustment, or augmentation of psychotropic medication(s) is indicated
• The treating clinician thinks PGx testing can benefit and refers the patient to the study

You may not qualify if…

• Unwillingness to donate saliva samples for genetic analysis
• History of liver or bone marrow (hematopoietic cell) transplantation
• PGx testing results are already available
• No personal health identification number (PHIN) is available

Where it is running

• University of Manitoba College of Pharmacy — Winnipeg, Manitoba, Canada (enrolling)
• Shared Health Facilities — Winnipeg, Manitoba, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.